Alternative Splicing Microarrays Reveal Functional Expression of Neuron-specific Regulators in Hodgkin Lymphoma Cells*

Alternative splicing provides a versatile mechanism of gene regulation, which is often subverted in disease. We have used customized oligonucleotide microarrays to interrogate simultaneously the levels of expression of splicing factors and the patterns of alternative splicing of genes involved in tumor progression. Analysis of RNAs isolated from cell lines derived from Hodgkin lymphoma tumors indicate that the relative abundance of alternatively spliced isoforms correlates with transformation and tumor grade. Changes in expression of regulators were also detected, and a subset sample was confirmed at the protein level. Ectopic expression of neuron-specific splicing regulatory proteins of the Nova family was observed in some cell lines and tumor samples, correlating with expression of a neuron-specific mRNA isoform of JNK2 kinase. This microarray design can help assess the role of alternative splicing in a variety of biological and medical problems and potentially serve as a diagnostic tool.

[1]  Martin Hofmann,et al.  A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells , 1991, Cell.

[2]  G. Davies-Jones,et al.  Paraneoplastic opsoclonus-myoclonus in Hodgkin's disease. , 1993, Journal of neurology, neurosurgery, and psychiatry.

[3]  R. Darnell,et al.  Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor system , 1993, Neuron.

[4]  H. K. Sluss,et al.  Selective interaction of JNK protein kinase isoforms with transcription factors. , 1996, The EMBO journal.

[5]  R. Darnell,et al.  The neuronal RNA-binding protein Nova-2 is implicated as the autoantigen targeted in POMA patients with dementia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[6]  R. Reed,et al.  Phosphorylation of spliceosomal protein SAP 155 coupled with splicing catalysis. , 1998, Genes & development.

[7]  Scott A. Rifkin,et al.  Microarray analysis of Drosophila development during metamorphosis. , 1999, Science.

[8]  F. Kittrell,et al.  Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis , 1999, Oncogene.

[9]  Dirk Bohmann,et al.  Diverse functions of JNK signaling and c-Jun in stress response and apoptosis , 1999, Oncogene.

[10]  J. Valcárcel,et al.  Alternative pre-mRNA splicing: the logic of combinatorial control. , 2000, Trends in biochemical sciences.

[11]  Robert B Darnell,et al.  Nova-1 Regulates Neuron-Specific Alternative Splicing and Is Essential for Neuronal Viability , 2000, Neuron.

[12]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[13]  D. Black.  Protein Diversity from Alternative Splicing A Challenge for Bioinformatics and Post-Genome Biology , 2000, Cell.

[14]  Ruben Abagyan,et al.  Match-Only Integral Distribution (MOID) Algorithm for high-density oligonucleotide array analysis , 2002, BMC Bioinformatics.

[15]  R. Stoughton,et al.  Experimental annotation of the human genome using microarray technology , 2001, Nature.

[16]  Angela Relógio,et al.  Optimization of oligonucleotide-based DNA microarrays. , 2002, Nucleic acids research.

[17]  Christopher J. Lee,et al.  A genomic view of alternative splicing , 2002, Nature Genetics.

[18]  Tyson A. Clark,et al.  Genomewide Analysis of mRNA Processing in Yeast Using Splicing-Specific Microarrays , 2002, Science.

[19]  A. Kornblihtt,et al.  Alternative splicing: multiple control mechanisms and involvement in human disease. , 2002, Trends in genetics : TIG.

[20]  Xiang-Dong Fu,et al.  Profiling alternative splicing on fiber-optic arrays , 2002, Nature Biotechnology.

[21]  B. Stürzenhofecker,et al.  Abundant Expression of Spliced HDM2 in Hodgkin Lymphoma Cells does not Interfere with p14ARF and p53 Binding , 2003, Leukemia & lymphoma.

[22]  Jernej Ule,et al.  CLIP Identifies Nova-Regulated RNA Networks in the Brain , 2003, Science.

[23]  H. Kestler,et al.  DNA microarray analysis in malignant lymphomas , 2003, Annals of Hematology.

[24]  V. Diehl,et al.  Profiling of Hodgkin’s Lymphoma Cell Line L1236 and Germinal Center B Cells: Identification of Hodgkin’s Lymphoma-specific Genes , 2003 .

[25]  Markus Beier,et al.  Validation of a novel, fully integrated and flexible microarray benchtop facility for gene expression profiling. , 2003, Nucleic acids research.

[26]  J. Castle,et al.  Genome-Wide Survey of Human Alternative Pre-mRNA Splicing with Exon Junction Microarrays , 2003, Science.

[27]  David Haussler,et al.  Gene structure-based splice variant deconvolution using a microarry platform , 2003, ISMB.

[28]  C. Sherr,et al.  Principles of Tumor Suppression , 2004, Cell.

[29]  Meenakshi Roy,et al.  Analysis of alternative splicing with microarrays: successes and challenges , 2004, Genome Biology.

[30]  B. Brinkman,et al.  Splice variants as cancer biomarkers. , 2004, Clinical biochemistry.

[31]  R. Darnell.  Paraneoplastic neurologic disorders: windows into neuronal function and tumor immunity. , 2004, Archives of neurology.